已发表SCI文章

2019.12.05
Characterization of Hyperprogression After Immunotherapy in a Lung Adenocarcinoma Patient With Strong Expression of Programmed Death Ligand 1

1.jpg2.jpg3.jpg4.jpg5.jpg

注：图片均来源于Journal of Thoracic Oncology

  返    回
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer